Expression of MicroRNAs in Adults with Celiac Disease: A Narrative Review
-
Published:2024-08-30
Issue:17
Volume:25
Page:9412
-
ISSN:1422-0067
-
Container-title:International Journal of Molecular Sciences
-
language:en
-
Short-container-title:IJMS
Author:
Rigo Francielen Furieri1, Oliveira Ellen Cristina Souza de1ORCID, Quaglio Ana Elisa Valencise2, Moutinho Bruna Damásio3, Di Stasi Luiz Claudio4ORCID, Sassaki Ligia Yukie1ORCID
Affiliation:
1. Department of Internal Medicine, Medical School, São Paulo State University (UNESP), Botucatu 18618-687, SP, Brazil 2. Verum Ingredients, Botucatu Technology Park, Botucatu 18605-525, SP, Brazil 3. Department of Gastroenterology, Division of Clinical Gastroenterology and Hepatology, University of São Paulo School of Medicine (USP), São Paulo 01246-903, SP, Brazil 4. Laboratory of Phytomedicines, Pharmacology and Biotechnology (PhytoPharmaTec), Department of Biophysics and Pharmacology, Institute of Biosciences, São Paulo State University (UNESP), Botucatu 18618-689, SP, Brazil
Abstract
Celiac disease (CD) is an immune-mediated enteropathy triggered by the ingestion of proline- and glutamine-rich proteins, widely termed “gluten”, in genetically susceptible individuals. CD induces an altered immune response that leads to chronic inflammation and duodenal mucosal damage. Currently, there are no specific tests for the accurate diagnosis of CD, and no drugs are available to treat this condition. The only available treatment strategy is lifelong adherence to a gluten-free diet. However, some studies have investigated the involvement of microRNAs (miRNAs) in CD pathogenesis. miRNAs are small noncoding ribonucleic acid molecules that regulate gene expression. Despite the growing number of studies on the role of miRNAs in autoimmune disorders, data on miRNAs and CD are scarce. Therefore, this study aimed to perform a literature review to summarize CD, miRNAs, and the potential interactions between miRNAs and CD in adults. This review shows that miRNA expression can suppress or stimulate pathways related to CD pathogenesis by regulating cell proliferation and differentiation, regulatory T-cell development, innate immune response, activation of the inflammatory cascade, focal adhesion, T-cell commitment, tissue transglutaminase synthesis, and cell cycle. Thus, identifying miRNAs and their related effects on CD could open new possibilities for diagnosis, prognosis, and follow-up of biomarkers.
Reference48 articles.
1. Gluten introduction, breastfeeding, and celiac disease: Back to the drawing board;Lebwohl;Am. J. Gastroenterol.,2016 2. Felli, C., Baldassarre, A., and Masotti, A. (2017). Intestinal and circulating MicroRNAs in coeliac disease. Int. J. Mol. Sci., 18. 3. Caio, G., Volta, U., Sapone, A., Leffler, D.A., De Giorgio, R., Catassi, C., and Fasano, A. (2019). Celiac disease: A comprehensive current review. BMC Med., 17. 4. Paolini, A., Sarshar, M., Felli, C., Bruno, S.P., Rostami-Nejad, M., Ferretti, F., Masotti, A., and Baldassarre, A. (2022). Biomarkers to monitor adherence to gluten-free diet by celiac disease patients: Gluten immunogenic peptides and urinary miRNAs. Foods, 11. 5. American College of Gastroenterology guidelines update: Diagnosis and management of celiac disease;Hill;Am. J. Gastroenterol.,2023
|
|